| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.5M | -5.4% | -24.2% |
| Cost of Revenue | $11.7M | -13.1% | -40.7% |
| Gross Profit | $38.8M | -2.8% | -17.3% |
| R&D Expense | $7.9M | -19.5% | -31.1% |
| SG&A Expense | $8.8M | -14.0% | -20.5% |
| Operating Income | $5.3M | +176.0% | +261.5% |
| Pre-tax Income | -$1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.8M | -44.5% | -61.9% |
| Accounts Receivable | $18.9M | -5.9% | -40.5% |
| Current Assets | $65.1M | -21.9% | -44.8% |
| Total Assets | $409.1M | -7.4% | -26.3% |
| Current Liabilities | $84.0M | -6.3% | -29.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.5M | — | — |
| Capital Expenditures | $1.3M | — | — |
| Investing Cash Flow | $8.0M | — | — |
| Financing Cash Flow | -$61.6M | — | — |
| Free Cash Flow | $17.2M | — | — |
| +89.5% |
| -14.8% |
| Income Tax | -$259K | -51.5% | -148.9% |
| Net Income | -$1.1M | +91.4% | +35.3% |
| EPS (Basic) | -$0.09 | +82.4% | +25.0% |
| EPS (Diluted) | -$0.09 | +82.4% | +25.0% |
| $328.8M |
| -8.2% |
| -23.9% |
| Stockholders' Equity | -$47.3M | -11.5% | -5309.5% |